Details for 2021166753
Up to date per 02.04.2026
Actions
Details for 2021166753
Granted/Registered
European Patent
15.12.2021 A
15.11.2023 B1
01.02.2013
US
201361759914 P
A61K 9/127 20060101AFI20210923BHEP
Owner
Celator Pharmaceuticals, Inc.3170 Porter Drive Palo Alto, CA 94304US
Representative
Representative
Babeluk Patentanwälte GmbHFlorianigasse 26/31080 WienAT
Inventor
HAYES, Mark, E San Francisco, CA California 94117US
NOBLE, Charles, O San Francisco, CA California 94107US
SZOKA, Francis, C., Jr. San Francisco, CA California 94116US
Information about Fees